Overview
Glucagon-Like Peptide-1 (GLP-1) is a 30-amino-acid incretin hormone produced by L-cells in the distal small intestine and colon in response to nutrient ingestion. It is derived from the proglucagon gene through tissue-specific post-translational processing. GLP-1 plays a central role in the regulation of glucose homeostasis, insulin secretion, and appetite. GLP-1 is the parent molecule of an entire class of FDA-approved diabetes and obesity medications — the GLP-1 receptor agonists. This class includes semaglutide (Ozempic®, Wegovy®), liraglutide (Victoza®), and tirzepatide. Research on native GLP-1 continues to be foundational for understanding the pharmacology of this drug class and for developing next-generation metabolic therapeutics.
Mechanism of Action
GLP-1 exerts its primary effects by binding to the GLP-1 receptor (GLP-1R), a class B G-protein coupled receptor expressed on pancreatic beta cells, the gastrointestinal tract, the heart, kidneys, and the central nervous system. GLP-1R activation stimulates adenylyl cyclase via Gαs. This increases intracellular cAMP levels and activates both PKA and EPAC (exchange protein directly activated by cAMP) signaling pathways. In pancreatic beta cells, this cascade potentiates glucose-stimulated insulin secretion (GSIS) in a glucose-dependent manner — a critical safety feature that means GLP-1 only stimulates insulin release when blood glucose is elevated, minimizing hypoglycemia risk. GLP-1 also i
Research Evidence
- Parent molecule of the GLP-1 receptor agonist drug class (semaglutide, liraglutide, tirzepatide)
- Glucose-dependent insulin secretion — stimulates insulin only when blood glucose is elevated
- Inhibits glucagon secretion from pancreatic alpha cells, reducing hepatic glucose output
- Central GLP-1R activation reduces appetite and food intake via hypothalamic pathways
- Slows gastric emptying, reducing postprandial glucose excursions
Bottom line: GLP-1 is the native hormone that the entire GLP-1 agonist drug class (Ozempic, Wegovy, Mounjaro) is built around. The research-grade peptide supplied by Purgo Labs has a very short half-life (~2 minutes) compared to pharmaceutical analogs, making it a precise research tool for studying GLP-1 receptor biology. For laboratory research use only.
Research Protocols & Dosage
Evidence-based research protocols, administration routes, and dosage considerations for GLP-1 are detailed in the full compound profile. See also: Dosage guide for GLP-1.
Sourcing & Quality
GLP-1 is available from Purgo Labs with third-party COA verification and research-grade purity standards. View GLP-1 at Purgo Labs.